ERNA-101

N/A

Report date: 2025/06/30 16:02:20

Base Information

Drug NameERNA-101
Drug Alias NameIL7/IL15-secreting iMSCs therapyL7/IL15-secreting induced mesenchymal stem cell therapyERNA-101
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionInterleukin-7 replacementsInterleukin-15 replacementsStem cell replacements
TargetsInterleukin-7Interleukin-15
Therapy Area/IndicationsOvarian NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErnexa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFactor Bioscience IncErnexa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A